Miami, FL (September 29, 2020) – Organicell Regenerative Medicine, Inc. (OTCBB: BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, announced that the U.S. Food and Drug Administration (FDA) granted expanded access for an intermediate size population allowing its proprietary therapeutic, Zofin for the treatment of COVID-19. [Read more…]
Stem Cell News
BioInformant's coverage of stem cell news includes iPS cells, mesenchymal stem cells, hematopoietic stem cells, neural stem cells and more.
As the first and only market research firm to specialize in stem cell news, BioInformant research has been cited by the Wall Street Journal, Xconomy, AABB, and Vogue Magazine.
Serving Fortune 500 leaders that include GE Healthcare, Pfizer, and Goldman Sachs, BioInformant is your global leader in stem cell industry news.
Ronawk Offering Free Samples of T-Blocks to Slash Stem Cell Expansion Costs & Labor Hours
OLATHE, Kansas — Ronawk, innovators in stem cell expansion technologies, has launched a trial program to provide its patented tissue-blocks (T-Blocks) to commercial cell producers and regenerative medicine partners. Their T-Blocks are a 3D matrix consumable product that enable the stem cell industry by providing means to increase stem cell production by 3,600 times vs. traditional expansion methods. [Read more…]
Three New COVID-19 Patients Treated with Zofin(TM) Report Improvement
Organicell Commences Phase I/II Clinical Trial Enrollment
Miami, FL (September 2, 2020) — Organicell Regenerative Medicine, Inc. (OTCBB: BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, announced that the U.S. Food and Drug Administration (FDA) granted emergency, expanded access approval to treat two mild to moderate COVID-19 patients and one “Long Hauler” post COVID-19 patient. [Read more…]
denovoMATRIX GmbH on the path to enabling cell-based therapies
Now awarded ISO 9001:2015 Certification for Quality Management System
As an organization, denovoMATRIX is driven by the undertaking of continuous improvement of our quality management system, a commitment to unremitting development of our staff and the fostering of customer relationships. denovoMATRIX GmbH is pleased to announce its ISO 9001:2015 Quality Management Standard certification by TÜV Süd. [Read more…]
FDA Clears Jointechlabs’ MiniTC for Point-of-Care Fat Tissue Processing and its Broad Range of Applications
San Francisco, CA – August 26, 2020 – Jointechlabs – a leader in point-of-care regenerative medicine therapies – today announced that the U.S. Food and Drug Administration (FDA) cleared the company’s MiniTCTM for point-of-care fat tissue processing designed to obtain microfat (or fat grafts), for multiple indications. Jointechlabs plans to focus on a range of therapeutic areas including medical aesthetics, plastic surgery, orthobiologics and wound healing. [Read more…]
- « Previous Page
- 1
- …
- 65
- 66
- 67
- 68
- 69
- …
- 122
- Next Page »